E-LIB Suche - Ergebnisse für: Milioli, Heloisa H.

1

The potential of epigenetic therapy to target the 3D epigen..:

Achinger-Kawecka, Joanna ; Stirzaker, Clare ; Portman, Neil...
Nature Structural & Molecular Biology. 31 (2024) 3 - p. 498-512 , 2024

Link: https://doi.org/10.1038/..

2

Innovative thiosemicarbazones that induce multi-modal mecha..:

Shehadeh-Tout, Faten ; Milioli, Heloisa H. ; Roslan, Suraya...
Pharmacological Research. 193 (2023) - p. 106806 , 2023

Link: https://doi.org/10.1016/..

3

The androgen receptor is a tumor suppressor in estrogen rec..:

Hickey, Theresa E. ; Selth, Luke A. ; Chia, Kee Ming...
Nature Medicine. 27 (2021) 2 - p. 310-320 , 2021

Link: https://doi.org/10.1038/..

4

MDM2 inhibition in combination with endocrine therapy and C..:

Portman, Neil ; Milioli, Heloisa H. ; Alexandrou, Sarah...
Breast Cancer Research. 22 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

5

Differential kynurenine pathway metabolism in highly metast..:

Heng, Benjamin ; Bilgin, Ayse A. ; Lovejoy, David B....
Breast Cancer Research. 22 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

6

Basal-like breast cancer: molecular profiles, clinical feat..:

Milioli, Heloisa H. ; Tishchenko, Inna ; Riveros, Carlos..
BMC Medical Genomics. 10 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

7

Iteratively refining breast cancer intrinsic subtypes in th..:

Milioli, Heloisa H. ; Vimieiro, Renato ; Tishchenko, Inna...
BioData Mining. 9 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

8

Differential kynurenine pathway metabolism in highly metast..:

Heng, Benjamin ; Bilgin, Ayse A ; Lovejoy, David B...
Heng , B , Bilgin , A A , Lovejoy , D B , Tan , V X , Milioli , H H , Gluch , L , Bustamante , S , Sabaretnam , T , Moscato , P , Lim , C K & Guillemin , G J 2020 , ' Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes : beyond IDO1-induced immunosuppression ' , Breast Cancer Research , vol. 22 , no. 1 , 113 , pp. 1-14 . https://doi.org/10.1186/s13058-020-01351-1. , 2020

Link: https://researchers.mq.e..

9

Differential kynurenine pathway metabolism in highly metast..:

Heng, Benjamin ; Bilgin, Ayse A ; Lovejoy, David B...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590459/. , 2020

Link: http://www.ncbi.nlm.nih...

10

MDM2 inhibition in combination with endocrine therapy and C..:

Portman, Neil ; Milioli, Heloisa H ; Alexandrou, Sarah...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425060/. , 2020

Link: http://www.ncbi.nlm.nih...

11

Differential kynurenine pathway metabolism in highly metast..:

Heng, Benjamin ; Bilgin, Ayse A ; Guillemin, Gilles J...
Breast Cancer Research Vol. 22, no. 113. , 2020

Link: http://hdl.handle.net/19..

12

Innovative thiosemicarbazones that induce multi-modal mecha..:

Faten Shehadeh-Tout ; Heloisa H. Milioli ; Suraya Roslan...
http://www.sciencedirect.com/science/article/pii/S1043661823001627. , 2023

Link: https://doi.org/10.1016/..

13

MDM2 inhibition in combination with endocrine therapy and C..:

Neil Portman ; Heloisa H. Milioli ; Sarah Alexandrou...
http://link.springer.com/article/10.1186/s13058-020-01318-2. , 2020

Link: https://doi.org/10.1186/..

14

Differential kynurenine pathway metabolism in highly metast..:

Benjamin Heng ; Ayse A. Bilgin ; David B. Lovejoy...
http://link.springer.com/article/10.1186/s13058-020-01351-1. , 2020

Link: https://doi.org/10.1186/..

15

Basal-like breast cancer: molecular profiles, clinical feat..:

Heloisa H. Milioli ; Inna Tishchenko ; Carlos Riveros..
http://link.springer.com/article/10.1186/s12920-017-0250-9. , 2017

Link: https://doi.org/10.1186/..